Analysts See $-0.57 EPS for Cellectis SA (ADR) (CLLS); Cadinha & Co Has Lifted Intel (INTC) Position By $340,131

November 15, 2017 - By Nellie Frank

Cadinha & Co Llc increased Intel Corp (INTC) stake by 16.66% reported in 2017Q2 SEC filing. Cadinha & Co Llc acquired 10,307 shares as Intel Corp (INTC)’s stock declined 2.96%. The Cadinha & Co Llc holds 72,162 shares with $2.44 million value, up from 61,855 last quarter. Intel Corp now has $214.62B valuation. The stock increased 0.24% or $0.11 during the last trading session, reaching $45.86. About 9,813 shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since November 15, 2016 and is uptrending. It has outperformed by 2.77% the S&P500.

Analysts expect Cellectis SA (ADR) (NASDAQ:CLLS) to report $-0.57 EPS on November, 28.They anticipate $0.17 EPS change or 42.50% from last quarter’s $-0.4 EPS. After having $-0.74 EPS previously, Cellectis SA (ADR)’s analysts see -22.97% EPS growth. The stock decreased 2.29% or $0.55 during the last trading session, reaching $23.46. About shares traded. Cellectis SA (ADR) (NASDAQ:CLLS) has declined 17.09% since November 15, 2016 and is downtrending. It has underperformed by 33.79% the S&P500.

Since June 5, 2017, it had 1 buy, and 0 insider sales for $504,204 activity. SWAN ROBERT HOLMES also bought $504,204 worth of Intel Corporation (NASDAQ:INTC) on Monday, June 5.

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 33 have Buy rating, 5 Sell and 16 Hold. Therefore 61% are positive. Intel Corporation had 198 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Thursday, June 1 by Jefferies. The company was maintained on Friday, January 15 by Roth Capital. The company was maintained on Wednesday, October 14 by Macquarie Research. The stock of Intel Corporation (NASDAQ:INTC) earned “Buy” rating by Brean Capital on Thursday, July 21. The stock has “Buy” rating by UBS on Monday, September 19. On Thursday, October 19 the stock rating was maintained by Canaccord Genuity with “Hold”. The rating was maintained by Raymond James with “Sell” on Wednesday, July 12. The stock has “Neutral” rating by Citigroup on Monday, September 19. As per Tuesday, September 20, the company rating was initiated by Susquehanna. The stock of Intel Corporation (NASDAQ:INTC) has “Buy” rating given on Wednesday, October 19 by Nomura.

Investors sentiment increased to 1.03 in 2017 Q2. Its up 0.02, from 1.01 in 2017Q1. It increased, as 78 investors sold INTC shares while 649 reduced holdings. 97 funds opened positions while 651 raised stakes. 3.05 billion shares or 0.13% less from 3.05 billion shares in 2017Q1 were reported. Proshare Advsrs Limited Liability Corporation holds 2.21 million shares. Cornerstone Inv Partners Limited Liability, Georgia-based fund reported 1.92M shares. Ancora Advisors Ltd holds 0.47% or 216,698 shares. Moreover, Monetary Management Group Inc has 0.51% invested in Intel Corporation (NASDAQ:INTC) for 37,167 shares. 12,493 are held by Mckinley Carter Wealth Svcs. Nichols & Pratt Advisers Llp Ma stated it has 439,792 shares. Tci Wealth Advisors stated it has 19,593 shares. Signalpoint Asset Lc has 1.82% invested in Intel Corporation (NASDAQ:INTC) for 20,160 shares. One National Association stated it has 68,782 shares or 0.17% of all its holdings. 26,552 are owned by Breton Hill Capital Limited. Connable Office invested 0.43% of its portfolio in Intel Corporation (NASDAQ:INTC). Bell Bankshares stated it has 66,419 shares. Sprucegrove Investment Mngmt Ltd stated it has 0.7% of its portfolio in Intel Corporation (NASDAQ:INTC). 29,970 are owned by Central Financial Bank Tru. Raymond James And Assocs reported 3.81 million shares or 0.28% of all its holdings.

Among 7 analysts covering Cellectis (NASDAQ:CLLS), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Cellectis had 13 analyst reports since April 5, 2016 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Tuesday, June 6 report. The company was maintained on Wednesday, August 16 by Oppenheimer. The company was maintained on Friday, June 2 by Oppenheimer. As per Friday, October 6, the company rating was maintained by SunTrust. Ladenburg Thalmann initiated Cellectis SA (ADR) (NASDAQ:CLLS) on Tuesday, April 5 with “Buy” rating. The rating was downgraded by SunTrust to “Hold” on Wednesday, September 6. The firm has “Buy” rating given on Wednesday, September 6 by Nomura. On Monday, October 2 the stock rating was downgraded by Morgan Stanley to “Sell”. Jefferies maintained Cellectis SA (ADR) (NASDAQ:CLLS) on Friday, October 27 with “Buy” rating. The company was maintained on Monday, September 25 by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: